DOCSLIB.ORG

Global Burden and Challenges of Melioidosis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Global Burden and Challenges of Melioidosis Global Burden and Challenges of Melioidosis Edited by Direk Limmathurotsakul and David AB Dance Printed Edition of the Special Issue Published in Tropical Medicine and Infectious Disease www.mdpi.com/journal/tropicalmed Global Burden and Challenges of Melioidosis Global Burden and Challenges of Melioidosis Special Issue Editors Direk Limmathurotsakul David AB Dance MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editors Direk Limmathurotsakul David AB Dance Mahidol University Lao-Oxford-Mahosot Hospital-Wellcome Trust Thailand Research Unit (LOMWRU) Laos Editorial Office MDPI St. Alban-Anlage 66 4052 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal Tropical Medicine and Infectious Disease (ISSN 2414-6366) from 2018 to 2019 (available at: https://www. mdpi.com/journal/tropicalmed/special issues/melioidosis) For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number, Page Range. ISBN 978-3-03897-742-1 (Pbk) ISBN 978-3-03897-743-8 (PDF) Cover image courtesy of Stephen Rudgard. c 2019 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons license CC BY-NC-ND. Contents About the Special Issue Editors ..................................... ix Preface to ”Global Burden and Challenges of Melioidosis” ..................... xi David AB Dance and Direk Limmathurotsakul Global Burden and Challenges of Melioidosis Reprinted from: Tropicalmed 2018, 3, 13, doi:10.3390/tropicalmed3010013 .............. 1 Ivo Steinmetz, Gabriel E. Wagner, Estelle Kanyala, Mamadou Sawadogo, Hema Soumeya, Mekonnen Teferi, Emawayish Andargie, Biruk Yeshitela, Louise Yaba Ats´e-Achi, Moussa Sanogo, et al. Melioidosis in Africa: Time to Uncover the True Disease Load Reprinted from: Tropicalmed 2018, 3, 13, doi:10.3390/tropicalmed3020062 .............. 4 Simon Smith, Josh Hanson and Bart J. Currie Melioidosis: An Australian Perspective Reprinted from: Tropicalmed 2018, 3, 27, doi:10.3390/tropicalmed3010027 .............. 13 Fazle Rabbi Chowdhury, Shariful Alam Jilani, Lovely Barai, Tanjila Rahman, Mili Rani Saha, Robed Amin, Kaniz Fatema, K. M. Shahidul Islam, M. A. Faiz, Susanna J. Dunachie and David A. B. Dance Melioidosis in Bangladesh: A Clinical and Epidemiological Analysis of Culture-Confirmed Cases Reprinted from: Tropicalmed 2018, 3, 40, doi:10.3390/tropicalmed3020040 .............. 24 Ketan Pande, Khairul Azmi Abd Kadir, Rosmonaliza Asli and Vui Heng Chong Melioidosis in Brunei Darussalam Reprinted from: Tropicalmed 2018, 3, 20, doi:10.3390/tropicalmed3010020 .............. 35 Sotharith Bory, Frances Daily, Gaetan Khim, Joanne Letchford, Srun Sok, Hero Kol, Muy Seang Lak, Luciano Tuseo, Chan Vibol, Sopheap Oeng and Paul Turner A Report from the Cambodia Training Event for Awareness of Melioidosis (C-TEAM), October 2017 Reprinted from: Tropicalmed 2018, 3, 23, doi:10.3390/tropicalmed3010023 .............. 47 Trung T. Trinh, Linh D. N. Nguyen, Trung V. Nguyen, Chuong X. Tran, An V. Le, Hao V. Nguyen, Karoline Assig, Sabine Lichtenegger, Gabriel E. Wagner, Cuong D. Do and Ivo Steinmetz Melioidosis in Vietnam: Recently Improved Recognition but still an Uncertain Disease Burden after Almost a Century of Reporting Reprinted from: Tropicalmed 2018, 3, 39, doi:10.3390/tropicalmed3020039 .............. 53 Grace Lui, Anthony Tam, Eugene Y. K. Tso, Alan K. L. Wu, Jonpaul Zee, Kin Wing Choi, Wilson Lam, Man Chun Chan, Wan Man Ting and Ivan F. N. Hung Melioidosis in Hong Kong Reprinted from: Tropicalmed 2018, 3, 91, doi:10.3390/tropicalmed3030091 .............. 65 v Andriniaina Rakotondrasoa, Mohammad Iqbal Issack, Benoˆıt Garin, Fabrice Biot, Eric Valade, Pierre Wattiau, Nicolas Allou, Olivier Belmonte, Jastin Bibi, Erin P. Price and Jean-Marc Collard Melioidosis in the Western Indian Ocean and the Importance of Improving Diagnosis, Surveillance, and Molecular Typing Reprinted from: Tropicalmed 2018, 3, 30, doi:10.3390/tropicalmed3010030 .............. 74 Patricia M. Tauran, Sri Wahyunie, Farahanna Saad, Andaru Dahesihdewi, Mahrany Graciella, Munawir Muhammad, Delly Chipta Lestari, Aryati Aryati, Ida Parwati, Tonny Loho, et al. Emergence of Melioidosis in Indonesia and Today’s Challenges Reprinted from: Tropicalmed 2018, 3, 32, doi:10.3390/tropicalmed3010032 .............. 88 David A.B. Dance, Manophab Luangraj, Sayaphet Rattanavong, Noikaseumsy Sithivong, Oulayphone Vongnalaysane, Manivanh Vongsouvath and Paul N. Newton Melioidosis in the Lao People’s Democratic Republic Reprinted from: Tropicalmed 2018, 3, 21, doi:10.3390/tropicalmed3010021 ..............102 Sheila Nathan, Sylvia Chieng, Paul Vijay Kingsley, Anand Mohan, Yuwana Podin, Mong-How Ooi, Vanitha Mariappan, Kumutha Malar Vellasamy, Jamuna Vadivelu, Sylvia Daim and Soon-Hin How Melioidosis in Malaysia: Incidence, Clinical Challenges, and Advances in Understanding Pathogenesis Reprinted from: Tropicalmed 2018, 3, 25, doi:10.3390/tropicalmed3010025 ..............109 Javier I. Sanchez-Villamil and Alfredo G. Torres Melioidosis in Mexico, Central America, and the Caribbean Reprinted from: Tropicalmed 2018, 3, 24, doi:10.3390/tropicalmed3010024 ..............128 Mo Mo Win, Elizabeth A. Ashley, Khwar Nyo Zin, Myint Thazin Aung, Myo Maung Maung Swe, Clare L. Ling, Fran¸cois Nosten, Win May Thein, Ni Ni Zaw, May Yee Aung, et al. Melioidosis in Myanmar Reprinted from: Tropicalmed 2018, 3, 28, doi:10.3390/tropicalmed3010028 ..............142 Jeffrey M. Warner and Bart J. Currie Melioidosis in Papua New Guinea and Oceania Reprinted from: Tropicalmed 2018, 3, 34, doi:10.3390/tropicalmed3010034 ..............151 Peter Franz M. San Martin, Joseph C. Chua, Ralph Louie P. Bautista, Jennifer M. Nailes, Mario M. Panaligan and David A. B. Dance Melioidosis in the Philippines Reprinted from: Tropicalmed 2018, 3, 99, doi:10.3390/tropicalmed3030099 ..............156 Siew Hoon Sim, Catherine Ee Ling Ong, Yunn Hwen Gan, Dongling Wang, Victor Wee Hong Koh, Yian Kim Tan, Michelle Su Yen Wong, Janet Seok Wei Chew, Sian Foong Ling, Brian Zi Yan Tan, et al. Melioidosis in Singapore: Clinical, Veterinary, and Environmental Perspectives Reprinted from: Tropicalmed 2018, 3, 31, doi:10.3390/tropicalmed3010031 ..............168 Dionne B. Rolim, Rachel Ximenes R. Lima, Ana Karoline C. Ribeiro, Rafael M. Colares, Leoniti D. Q. Lima, Alfonso J. Rodr´ıguez-Morales, Franco E. Montufar ´ and David A. B. Dance Melioidosis in South America Reprinted from: Tropicalmed 2018, 3, 60, doi:10.3390/tropicalmed3020060 ..............185 vi Enoka M. Corea, Aruna Dharshan de Silva and Vasanthi Thevanesam Melioidosis in Sri Lanka Reprinted from: Tropicalmed 2018, 3, 22, doi:10.3390/tropicalmed3010022 ..............193 Chiranjay Mukhopadhyay, Tushar Shaw, George M. Varghese and David A. B. Dance Melioidosis in South Asia (India, Nepal, Pakistan, Bhutan and Afghanistan) Reprinted from: Tropicalmed 2018, 3, 51, doi:10.3390/tropicalmed3020051 ..............204 Pei-Tan Hsueh, Wei-Tien Huang, Hsu-Kai Hsueh, Ya-Lei Chen and Yao-Shen Chen Transmission Modes of Melioidosis in Taiwan Reprinted from: Tropicalmed 2018, 3, 26, doi:10.3390/tropicalmed3010026 ..............218 Soawapak Hinjoy, Viriya Hantrakun, Somkid Kongyu, Jedsada Kaewrakmuk, Tri Wangrangsimakul, Siroj Jitsuronk, Weerawut Saengchun, Saithip Bhengsri, Thantapat Akarachotpong, Somsak Thamthitiwat, et al. Melioidosis in Thailand: Present and Future Reprinted from: Tropicalmed 2018, 3, 38, doi:10.3390/tropicalmed3020038 ..............228 Xiao Zheng, Qianfeng Xia, Lianxu Xia and Wei Li Endemic Melioidosis in Southern China: Past and Present Reprinted from: Tropicalmed 2019, 4, 39, doi:10.3390/tropicalmed3020039 ..............244 vii About the Special Issue Editors Direk Limmathurotsakul (Associate Professor, Mahidol University) studied medicine at Chulalongkorn University, Thailand. He obtained a PhD in Life and Biomolecular sciences from the Open University, UK, in 2008, and an MSc in Medical Statistics at the London School of Hygiene and Tropical Medicine in 2009. Since 2004, he has been working at the Mahidol-Oxford Tropical Medicine Research Unit (MORU), Mahidol University, mainly on melioidosis. He also works on sepsis and antimicrobial resistance. From 2012–present (2019), Direk has also run a Wellcome Trust-funded Intermediate Fellowship programme on melioidosis. He is also chair of the International Melioidosis Society (http://www.melioidosis.info) and the Melioidosis Threat Reduction Network (Melioidosis TRN). Direk has convened and contributed to a number of meetings about melioidosis between researchers and policy makers in multiple countries, including Thailand, Vietnam, Malaysia, Cambodia, Indonesia, India, Sri Lanka, and Brazil. These have helped to attract the attention of public health officials and policy makers, with the result that at last actions are being taken to improve diagnosis, treatment, and prevention of melioidosis in many tropical countries. David Dance (Honorary Visiting Research Fellow, University of Oxford; Honorary Professor, London School of Hygiene and Tropical Medicine)
Load more

Recommended publications
  • Q Fever in Small Ruminants and Its Public Health Importance
    Journal of Dairy & Veterinary Sciences ISSN: 2573-2196 Review Article Dairy and Vet Sci J Volume 9 Issue 1 - January 2019 Copyright © All rights are reserved by Tolera Tagesu Tucho DOI: 10.19080/JDVS.2019.09.555752 Q Fever in Small Ruminants and its Public Health Importance Tolera Tagesu* School of Veterinary Medicine, Jimma University, Ethiopia Submission: December 01, 2018; Published: January 11, 2019 *Corresponding author: Tolera Tagesu Tucho, School of Veterinary Medicine, Jimma University, Jimma Oromia, Ethiopia Abstract Query fever is caused by Coxiella burnetii, it’s a worldwide zoonotic infectious disease where domestic small ruminants are the main reservoirs for human infections. Coxiella burnetii, is a Gram-negative obligate intracellular bacterium, adapted to thrive within the phagolysosome of the phagocyte. Humans become infected primarily by inhaling aerosols that are contaminated with C. burnetii. Ingestion (particularly drinking raw milk) and person-to-person transmission are minor routes. Animals shed the bacterium in urine and feces, and in very high concentrations in birth by-products. The bacterium persists in the environment in a resistant spore-like form which may become airborne and transported long distances by the wind. It is considered primarily as occupational disease of workers in close contact with farm animals or processing their be commenced immediately whenever Q fever is suspected. To prevent both the introduction and spread of Q fever infection, preventive measures shouldproducts, be however,implemented it may including occur also immunization in persons without with currently direct contact. available Doxycycline vaccines drugof domestic is the first small line ruminant of treatment animals for Q and fever.
    [Show full text]
  • Zoonotic Diseases of Public Health Importance
    ZOONOTIC DISEASES OF PUBLIC HEALTH IMPORTANCE ZOONOSIS DIVISION NATIONAL INSTITUTE OF COMMUNICABLE DISEASES (DIRECTORATE GENERAL OF HEALTH SERVICES) 22 – SHAM NATH MARG, DELHI – 110 054 2005 List of contributors: Dr. Shiv Lal, Addl. DG & Director Dr. Veena Mittal, Joint Director & HOD, Zoonosis Division Dr. Dipesh Bhattacharya, Joint Director, Zoonosis Division Dr. U.V.S. Rana, Joint Director, Zoonosis Division Dr. Mala Chhabra, Deputy Director, Zoonosis Division FOREWORD Several zoonotic diseases are major public health problems not only in India but also in different parts of the world. Some of them have been plaguing mankind from time immemorial and some have emerged as major problems in recent times. Diseases like plague, Japanese encephalitis, leishmaniasis, rabies, leptospirosis and dengue fever etc. have been major public health concerns in India and are considered important because of large human morbidity and mortality from these diseases. During 1994 India had an outbreak of plague in man in Surat (Gujarat) and Beed (Maharashtra) after a lapse of around 3 decades. Again after 8 years in 2002, an outbreak of pneumonic plague occurred in Himachal Pradesh followed by outbreak of bubonic plague in 2004 in Uttaranchal. Japanese encephalitis has emerged as a major problem in several states and every year several outbreaks of Japanese encephalitis are reported from different parts of the country. Resurgence of Kala-azar in mid seventies in Bihar, West Bengal and Jharkhand still continues to be a major public health concern. Efforts are being made to initiate kala-azar elimination programme by the year 2010. Rabies continues to be an important killer in the country.
    [Show full text]
  • Cholera Transmission: the Host, Pathogen and Bacteriophage Dynamic
    REVIEWS Cholera transmission: the host, pathogen and bacteriophage dynamic Eric J. Nelson*, Jason B. Harris‡§, J. Glenn Morris Jr||, Stephen B. Calderwood‡§ and Andrew Camilli* Abstract | Zimbabwe offers the most recent example of the tragedy that befalls a country and its people when cholera strikes. The 2008–2009 outbreak rapidly spread across every province and brought rates of mortality similar to those witnessed as a consequence of cholera infections a hundred years ago. In this Review we highlight the advances that will help to unravel how interactions between the host, the bacterial pathogen and the lytic bacteriophage might propel and quench cholera outbreaks in endemic settings and in emergent epidemic regions such as Zimbabwe. 15 O antigen Diarrhoeal diseases, including cholera, are the leading progenitor O1 El Tor strain . Although the O139 sero- The outermost, repeating cause of morbidity and the second most common cause group caused devastating outbreaks in the 1990s, the El oligosaccharide portion of LPS, of death among children under 5 years of age globally1,2. Tor strain remains the dominant strain globally11,16,17. which makes up the outer It is difficult to gauge the exact morbidity and mortality An extensive body of literature describes the patho- leaflet of the outer membrane of Gram-negative bacteria. of cholera because the surveillance systems in many physiology of cholera. In brief, pathogenic strains har- developing countries are rudimentary, and many coun- bour key virulence factors that include cholera toxin18 Cholera toxin tries are hesitant to report cholera cases to the WHO and toxin co-regulated pilus (TCP)19,20, a self-binding A protein toxin produced by because of the potential negative economic impact pilus that tethers bacterial cells together21, possibly V.
    [Show full text]
  • 2012 Case Definitions Infectious Disease
    Arizona Department of Health Services Case Definitions for Reportable Communicable Morbidities 2012 TABLE OF CONTENTS Definition of Terms Used in Case Classification .......................................................................................................... 6 Definition of Bi-national Case ............................................................................................................................................. 7 ------------------------------------------------------------------------------------------------------- ............................................... 7 AMEBIASIS ............................................................................................................................................................................. 8 ANTHRAX (β) ......................................................................................................................................................................... 9 ASEPTIC MENINGITIS (viral) ......................................................................................................................................... 11 BASIDIOBOLOMYCOSIS ................................................................................................................................................. 12 BOTULISM, FOODBORNE (β) ....................................................................................................................................... 13 BOTULISM, INFANT (β) ...................................................................................................................................................
    [Show full text]
  • Plague (Yersinia Pestis)
    Division of Disease Control What Do I Need To Know? Plague (Yersinia pestis) What is plague? Plague is an infectious disease of animals and humans caused by the bacterium Yersinia pestis. Y. pestis is found in rodents and their fleas in many areas around the world. There are three types of plague: bubonic plague, septicemic plague and pneumonic plague. Who is at risk for plague? All ages may be at risk for plague. People usually get plague from being bitten by infected rodent fleas or by handling the tissue of infected animals. What are the symptoms of plague? Bubonic plague: Sudden onset of fever, headache, chills, and weakness and one or more swollen and painful lymph nodes (called buboes) typically at the site where the bacteria entered the body. This form usually results from the bite of an infected flea. Septicemic plague: Fever, chills, extreme weakness, abdominal pain, shock, and possibly bleeding into the skin and other organs. Skin and other tissues, especially on fingers, toes, and the nose, may turn black and die. This form usually results from the bites of infected fleas or from handling an infected animal. Pneumonic plague: Fever, headache, weakness, and a rapidly developing pneumonia with shortness of breath, chest pain, cough, and sometimes bloody or watery mucous. Pneumonic plague may develop from inhaling infectious droplets or may develop from untreated bubonic or septicemic plague after the bacteria spread to the lungs. How soon do symptoms appear? Symptoms of bubonic plague usually occur two to eight days after exposure, while symptoms for pneumonic plague can occur one to six days following exposure.
    [Show full text]
  • School of Health Sciences Newsletter August 2014 CONTENTS HEAD OF
    School of Health Sciences Newsletter August 2014 CONTENTS Head of School Report Presentations (Teaching and Research) Did you know? Research News UniSA – PAFC Official Launch Publications by Staff and Students Staff Appointments and News School Administration Teaching and Learning HEAD OF SCHOOL Hi All Welcome to the August Newsletter. Staff Appointments I am pleased to report the appointments of Sandy Maranna as Lecturer in Medical Sonography; Cathy Cookson as Lecturer in Medical Sonography; Caroline Fryer and Emily Ward as Lecturers in Physiotherapy; Michael Dale as Lecturer in Human Movement and Narelle Korotkov as Academic Services Officer (Health Sciences and Occupational Therapy). Port Adelaide Football Club (PAFC) Partnership Launch TV personality and President of the club (David Koch) and Professor David Lloyd (Vice-Chancellor) presided over the PAFC partnership launch, with distinguished guests including Hon Tom Kenyon MP and Hon Susan Close MP, and Dr Ian Gould (Chancellor), Sir Eric Neal and representatives of SA’s leading sports organisations, commercial partners, stakeholders and friends of PAFC and UniSA. The University has a long relationship with PAFC which includes a sports science PhD scholarship, sponsored annual student prizes, cadetships, UniSA support for the annual Aboriginal Cup carnival and the Gavin Wanganeen Indigenous scholarship. The launch marked the signing of a MoU in June to form a high performance partnership centred on research and education in elite sport, a commitment to community engagement to provide effective communication to remote Aboriginal communities and the development of strategies to explore compatible connections in China and Asia. Among the exciting announcements made by David Koch and David Lloyd, were plans to launch a High Performance MSc preceded by a pilot program of two modules in 2015, development of a UniSA scholarship to conduct research in relation to PAFC’s WillPower program into communities in the APY lands and a scholarship to a student from a university in China to work with PAFC and UniSA.
    [Show full text]
  • CASE REPORT the PATIENT 33-Year-Old Woman
    CASE REPORT THE PATIENT 33-year-old woman SIGNS & SYMPTOMS – 6-day history of fever Katherine Lazet, DO; – Groin pain and swelling Stephanie Rutterbush, MD – Recent hiking trip in St. Vincent Ascension Colorado Health, Evansville, Ind (Dr. Lazet); Munson Healthcare Ostego Memorial Hospital, Lewiston, Mich (Dr. Rutterbush) [email protected] The authors reported no potential conflict of interest THE CASE relevant to this article. A 33-year-old Caucasian woman presented to the emergency department with a 6-day his- tory of fever (103°-104°F) and right groin pain and swelling. Associated symptoms included headache, diarrhea, malaise, weakness, nausea, cough, and anorexia. Upon presentation, she admitted to a recent hike on a bubonic plague–endemic trail in Colorado. Her vital signs were unremarkable, and the physical examination demonstrated normal findings except for tender, erythematous, nonfluctuant right inguinal lymphadenopathy. The patient was admitted for intractable pain and fever and started on intravenous cefoxitin 2 g IV every 8 hours and oral doxycycline 100 mg every 12 hours for pelvic inflammatory disease vs tick- or flea-borne illness. Due to the patient’s recent trip to a plague-infested area, our suspicion for Yersinia pestis infection was high. The patient’s work-up included a nega- tive pregnancy test and urinalysis. A com- FIGURE 1 plete blood count demonstrated a white CT scan from admission blood cell count of 8.6 (4.3-10.5) × 103/UL was revealing with a 3+ left shift and a platelet count of 112 (180-500) × 103/UL. A complete metabolic panel showed hypokalemia and hyponatremia (potassium 2.8 [3.5-5.1] mmol/L and sodium 134 [137-145] mmol/L).
    [Show full text]
  • Plague Information for Veterinarians
    PLAGUE in NEW MEXICO: INFORMATION FOR VETERINARIANS General Information Plague is caused by Yersinia pestis, a gram-negative bacterium that is endemic to most of the western United States. Epizootics of plague occur in wild rodents (rock squirrels, prairie dogs, ground squirrels, chipmunks, woodrats, and others) and most people acquire plague by the bite of an infectious rodent flea. However, about one-fifth of all human cases result from direct contact with infected animals. Cats are particularly susceptible to plague and can play a role in transmission to humans by a variety of mechanisms including transporting infected fleas or rodent/rabbit carcasses into the residential environment, direct contact contamination with exudates or respiratory droplets, and by bites or scratches. Cat-associated human cases were first reported in 1977. In a study by Gage (2000), 23 human plague cases were associated with exposure to infected cats, including 5 cases among veterinarians and veterinary assistants. Dogs are frequently infected with Y. pestis, develop antibodies to the organism, and occasionally exhibit clinical signs. However, dogs have not been shown to be direct sources of human infection. Dogs can transport infected fleas or rodent/rabbit carcasses into the residential environment, leading to plague transmission to people. Plague-infected ungulates have rarely been identified. Plague in Cats and Dogs Clinical features In enzootic areas, plague should be considered in the differential diagnosis of fever of unknown origin in cats and dogs. In a study of plague in cats by Eidson (1991), 53% of cats had bubonic plague, 8% were septicemic, and 10% had plague pneumonia.
    [Show full text]
  • AMD Projects: Deadly Disease Databases
    CDC’s AMD Program AMD Projects Innovate • Transform • Protect CDC’s Advanced Molecular Detection (AMD) program fosters scientific innovation in genomic sequencing, epidemiology, and bioinformatics to transform public health and protect people from disease threats. AMD Project: Deadly Disease Databases Whole genome analysis and database development for anthrax (Bacillus anthracis), melioidosis (Burkholderia pseudomallei), and Brucellosis (Brucella spp.) Epidemiologists and forensic professionals can use whole genome sequencing – a way of determining an organism’s complete, detailed genome – and large databases to determine the source of dangerous germs. Having a large, accessible collection of disease pathogens could help scientists quickly find out if a certain illness is naturally occurring or the result of bioterrorism. CDC is establishing a public database where scientists from around the world can share information about these potentially deadly CDC is establishing public databases so that diseases. CDC scientists have begun sequencing the organisms that scientists from around the world can share information about deadly diseases like cause anthrax (Bacillus anthracis), brucellosis (Brucella spp.), and anthrax, brucellosis, and melioidosis. melioidosis (Burkholderia pseudomallei), three pathogens that could occur naturally or as the result of bioterrorism. Current methods of determining the genetic structure of these organisms are not standardized and sometimes not effective. Using whole genome sequencing for these pathogens will allow scientists www.cdc.gov/amd Updated: May 2017 to accurately and quickly find the geographic origin of the isolates and will improve overall knowledge and understanding of them. Having a detailed database of these genomes will also ensure quicker and more effective responses to outbreaks. For more information on anthrax, please visit www.cdc.gov/anthrax/index.html.
    [Show full text]
  • Vibrio Cholerae O1, O139)
    Cholera! (Toxigenic Vibrio cholerae O1, O139) Note: Only toxigenic strains of Vibrio cholerae serogroups O1 and O139 cause epidemics and are reportable as cholera. This guidance is intended for management of patients with toxigenic strains of V. cholerae serogroups O1 and O139 and early management (i.e., before laboratory confirmation is available) of patients with cholera-like illness returning from regions where cholera activity has been reported (e.g., travelers returning from Haiti or the Dominican Republic). For management of non-toxigenic strains of V. cholerae O1 and O139, toxigenic strains of other V. cholerae serogroups (e.g. O75 and O141), and other Vibrio species, refer to the guidance for vibriosis. PROTOCOL CHECKLIST Enter available information into Merlin within 24 hours of notification Review background on disease, case definition, laboratory testing (section 2, 3, and 4) Contact provider (section 5) Confirm diagnosis Obtain available demographic and clinical information Determine what information was provided to the patient Ensure collection and submission of appropriate specimens (section 4) Interview patient(s) (section 5) Review disease facts (section 2) Description of illness Modes of transmission Ask about exposure to relevant risk factors (section 5) Travel to an area affected by cholera Exposure to untreated water sources Exposure to raw shellfish or undercooked seafood Consumption of food imported from an area affected by cholera Pre-existing conditions Identify any similar cases of illness among contacts Determine
    [Show full text]
  • The Plague of Thebes, a Historical Epidemic in Sophocles' Oedipus
    Oedipus Rex) is placed in the fi rst half of the decade 430– The Plague 420 BC. The play has been labeled an analytical tragedy, meaning that the crucial events which dominate the play of Thebes, a have happened in the past (2,3). Oedipus Rex, apart from the undeniable literary and Historical Epidemic historic value, also presents signifi cant medical interest because the play mentions a plague, an epidemic, which in Sophocles’ was devastating Thebes, the town of Oedipus’ hegemony. Oedipus Rex Several sections, primarily in the fi rst third of the play, refer to the aforementioned plague; the epidemic, however, Antonis A. Kousoulis, is not the primary topic of the tragedy. The epidemic, in Konstantinos P. Economopoulos, fact, is mostly a matter that serves the theatrical economy Effi e Poulakou-Rebelakou, George Androutsos, by forming a background for the evolution of the plot. and Sotirios Tsiodras Given the potential medical interest of Oedipus Rex, we decided to adopt a critical perspective by analyzing the Sophocles, one of the most noted playwrights of the literary descriptions of the plague, unraveling its clinical ancient world, wrote the tragedy Oedipus Rex in the fi rst features, defi ning the underlying cause, and discussing half of the decade 430–420 BC. A lethal plague is described in this drama. We adopted a critical approach to Oedipus possible therapeutic options. The ultimate goals of our Rex in analyzing the literary description of the disease, study were to clarify whether the plague described in unraveling its clinical features, and defi ning a possible Oedipus Rex could refl ect an actual historical event, underlying cause.
    [Show full text]
  • Biannual Communicable Disease Surveillance Report #2
    BIANNUAL COMMUNICABLE DISEASE SURVEILLANCE REPORT #2 An overview of the public health nurse surveillance of THE TOWN communicable diseases in Grafton, MA, Jan 1 – Dec 31, 2020. 2020OF GRAFTON Grafton Biannual Communicable Disease Surveillance Report #2, 2020 Defining Case Classifications for Communicable Diseases In the U.S., the States mandate the reporting of certain diseases by law or by regulation. The diseases that are reportable to state and local health departments differ from state to state; however, certain diseases are considered nationally notifiable diseases. The list of nationally notifiable diseases is updated annually. The Centers for Disease Control and Prevention (CDC), in collaboration with the Council of State and Territorial Epidemiologists (CSTE), publishes case definitions for public health surveillance for the nationally notifiable diseases. These case definitions provide uniform criteria for reporting cases and are case specific. The case status for most diseases is determined as follows: • A confirmed case is one in which the clinical case description is met and the laboratory confirmation requirement is met. A case may also be considered confirmed if it is linked to a laboratory-confirmed case. Certain diseases may not include laboratory findings as testing is not available. • A probable case is one in which the clinical case description is met and there is supportive or presumptive laboratory results consistent with the diagnosis but, it does not meet the laboratory confirmed criteria. • A suspect case is one in which the clinical case description is met. • A revoked case is one in which neither the suspect, probable, nor confirmed case definition is met. A significant amount of information gathering must be collected for many diseases before a case classification is final.
    [Show full text]